Articles

News

Saiba mais sobre a parceria Fiocruz+Universidade de Oxford para a produção de uma vacina contra a COVID-19

Fiocruz will be testing BCG vaccine for the prevention of Covid-19 in Brazil

Existing studies shows that the BCG vaccine is efficient against other viral respiratory infections

24/09/2020 Regina Castro In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The ... Read more

Portable device developed by Fiocruz may popularize molecular tests for COVID-19

The OmniLAMP makes it possible to run tests with safety levels similar to those of the PCR, but in a shorter time and at a lower cost

11/09/2020 Fiocruz Minas Researchers of Fiocruz and Visuri, reference institutions in research and development of technology for health, have developed a portable device, the OmniLAMP, for the molecular diagnosis of COVID-19 through the detection of SARS-CoV-2 genetic material. Using the ... Read more

Fiocruz and Eatris sign partnership for translational science

The partnership includes not only education and training projects within this theme, but also the creation of a Global Hub of Drug Repositioning, with an initial focus on neglected and rare diseases.

13/10/2020 Gardênia Vargas (CDTS/Fiocruz) The Center for Technological Development in Health of the Oswaldo Cruz Foundation (CDTS/Fiocruz) and the European Infrastructure for Translational Medicine (Eatris) signed, in September, a letter of intent with the goal of promoting initiatives in translational ... Read more

Fiocruz and Inmetro record images of coronavirus in action

Obtained through high-resolution microscopy, the photographs show that infected cells show membrane extensions, called filopodia, that form intercellular connections.

07/10/2020 Maíra Menezes (IOC/Fiocruz) In a partnership with the National Institute of Metrology, Quality, and Technology (Inmetro), researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) have recorded new images that reveal the effects of the infection by the new coronavirus in ... Read more

Study suggests Covid-19 may cause brain damage

The research have observed that the SARS-CoV-2 can infect neural cells and create brain damage

24/09/2020 Regina Castro In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The ... Read more

Survey shows how Brazilians see Fiocruz in twelve cities

The goal was to analyze the perception society has of the Foundation. The survey investigated the knowledge regarding the institution, its relevance, the performance of available services among other issues.

15/10/2020 Ricardo Valverde As part of the celebrations of the 120th anniversary of the Oswaldo Cruz Foundation, the National Institute of Public Communication in Science and Technology (INCT-CPCT) has coordinated the survey How Brazilians see Fiocruz: a survey in 12 ... Read more

Fiocruz is designated as reference institution in Covid-19 in the Americas for the WHO

The Laboratory for Respiratory Viruses and Measles has been formally acknowledged as reference in the continent, together with the CDC

Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more

Return to school is a risk for more than 9.3 million adults in Brazil

The number was calculated through a Fiocruz analysis, along with other partners, based on the National Health Survey (PNS 2013),

27/07/2020 Icict/Fiocruz Going back to school may represent an extra risk for more than 9.3 million Brazilians (4.4% of the overall population) who are elderly or adults (18 years and up) with chronic health conditions and at risk for Covid-19 ... Read more

Understanding the gendered dimensions of - COVID-19 - #InFocus

Watch the webinar in English 

  

E-Learning